B12 Slows Functional Decline in Early-stage ALS, Data Show Written by | Treatment with ultrahigh-dose methylcobalamin the physiologically active form of vitamin B12 effectively slowed functional decline in people with early-stage amyotrophic lateral sclerosis (ALS) and moderate progression, data from a small Phase 3 trial in Japan show
Although human proteomic data from ex vivo acinar-cell preparations support the relevance of stress-associated organellar injury in pancreatitis-relevant conditions, these systems do not reproduce the full multicellular, vascular, stromal, and immune complexity of clinical AP ( 2+ dysregulation, and mitochondrial failure cannot usually be studied at the stage when they are most likely to be mechanistically informative
SFN also enhanced expression of genes associated with synapse formation
10.1016/j.freeradbiomed.2024.04.229 43 DegterevA.HitomiJ.GermscheidM.ChenI
NNMT inhibition plus a lean diet accelerates weight/fat loss, improves body-composition indices, and normalizes several liver pathologies versus diet alone [3,4]
